Print…

Tipo de Resultado

Procurou por: Whatman products (Cytiva)

596  resultados encontrados

Upstream Gene Therapy Products & Solutions in Bioprocessing

Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...

Avantor accelerates Cell and Gene Therapy (C>) production

Avantor accelerates Cell and Gene Therapy (C>) production Your Role Your Challenge Our Services Portfolio Resources About Us Contact Us Challenge A global pharmaceutical company set an ambitious strategic goal of transitioning from Cell and Gene...

Cell Therapy Products, Workflow & Research Services

Cell Therapy Products Workflow & Research Services Cell therapies encompass several approaches that require the manipulation of donor tissue both autologous and allogeneic to obtain desired cells and tissues. These cells and tissues are then used ...

Life Science Research Solutions, Products & Resources

Life Science Avantor® can help equip your life sciences lab with the products equipment and supplies you'll need whether you work in cell biology genomics proteomics or other fields. We carry millions of products from brands you trust so you can c...

Streamlining Procurement and Inventory Management Leads to Increased Productivity

Streamlining Procurement and Inventory Management Leads to Increased Productivity Your Role Your Challenge Our Services Portfolio Resources About Us Contact Us Challenge In addition to planning a relocation to a new headquarters to accommodate gro...

Lean Inventory Management Program Reduces Costs for Production Environment

Lean Inventory Management Program Reduces Costs for Production Environment Your Role Your Challenge Our Services Portfolio Resources About Us Contact Us Challenge The high costs of managing cleanroom consumables inventory were dragging down the ov...

Stability Testing of New Drug Substances and Products Q1A (R2)

Stability Testing of New Drug Substances and Products Q1A (R2) Webinar Tuesday 15th October 2019 11:00 to 12:00 CEST (Berlin Paris Madrid) PRESENTED IN ENGLISH Replay Email Alerts Free Registration Chat Area Certificate of attendance

Stability Testing of New Drug Substances and Products Q1A (R2)

Stability Testing of New Drug Substances and Products Q1A (R2) Webinar Tuesday 26th October 2021 11:00 to 12:00 CEST (Berlin Paris Madrid) Register now! Email Alerts Free Registration Chat Area Certificate of attendance To improve the quality of t...

Inventory System Streamlines Procurement for cGMP Drug Production Facility

Inventory System Streamlines Procurement for cGMP Drug Production Facility Your Role Your Challenge Our Services Portfolio Resources About Us Contact Us Challenge An unstable system for managing production supplies often leads to interruptions in ...

The Safer Choice: Improving Safety in the Lab through product selection and usage

The Safer Choice: Improving Safety in the Lab through product selection and usage Webinar Thursday 3rd February 2022 11:00 to 12:00 CET (Berlin Paris Madrid) Replay Email Alerts Free Registration Chat Area Certificate of attendance The Safer Choic...

Ansell Guardian® - helps companies select the right PPE solution to improve safety, productivity and cost performance.

Ansell Guardian® - helps companies select the right PPE solution to improve safety productivity and cost performance. Webinar Tuesday 29th September 2020 11:00 to 12:00 CEST (Berlin Paris Madrid) Replay Email Alerts Free Registration Chat Area Cer...

Final fill for vaccines

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Avantor Services Cell and Gene Therapy Success Sto

Success story Avantor accelerates Cell and Gene Therapy (C>) production Avantor Services Lab and production services CHALLENGE A global pharmaceutical company set an ambitious strategic goal of transitioning from Cell and Gene Therapy (C>) con...

Upstream processing for cell therapy

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Final fill for recombinant proteins

Final fill for recombinant proteins Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepar...

Upstream processing for microbial-based recombinant proteins

Upstream processing for microbial-based recombinant proteins Using microbial fermentation for the development and manufacture of recombinant proteins keeps on showing advantages e.g for the expression of proteins that do not require post-translati...
33 - 48 of 596